Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $180

Moomoo NewsOct 24 07:36 ET · Ratings

Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Collegium Pharmaceutical (COLL) and Korro Bio (KRRO)

TipRanksOct 24 06:41 ET · Ratings

Korro Bio Insider Sold Shares Worth $799,527, According to a Recent SEC Filing

MT NewswiresOct 21 09:26 ET

RBC Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Raises Target Price to $105

Moomoo NewsOct 21 07:31 ET · Ratings

Raymond James Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $153

Moomoo NewsOct 21 07:31 ET · Ratings

RBC Raises Price Target on Korro Bio to $105 From $95, Keeps Outperform, Speculative Risk

MT NewswiresOct 21 07:08 ET · Ratings